Integrin Receptor Antagonists

Integrin Receptor Antagonist

Colitis, Ulcerative

Crohn Disease

Enteritis

<section class="Section" data-sectioncode="34089-3"><a name="S11"></a><a name="section-9"></a><p></p><h1>11 DESCRIPTION</h1><p class="First">Vedolizumab, an integrin receptor antagonist, is a humanized IgG<span class="Sub">1 </span>monoclonal antibody produced in Chinese hamster ovary cells that binds to the human α4β7 integrin. ENTYVIO has an approximate molecular weight of 147 kilodaltons.</p><div class="Section" data-sectioncode="42229-5"><a name="section-9.1"></a><p></p><p class="First"><span class="Italics Underline">Intravenous ENTYVIO</span></p><p>ENTYVIO (vedolizumab) for injection is supplied as a sterile, white to off-white, preservative-free, lyophilized cake for intravenous infusion. After reconstitution with 4.8 mL Sterile Water for Injection, USP, 0.9% Sodium Chloride Injection, USP, or Lactated Ringer's Injection, USP, the resulting concentration is 60 mg/mL with a deliverable volume of 5 mL (300 mg) and the resulting pH is approximately 6.3.</p><p>Each single-dose vial contains 300 mg vedolizumab, arginine hydrochloride (131.7 mg), histidine (23 mg), histidine monohydrochloride (21.4 mg), polysorbate 80 (3 mg), and sucrose (500 mg).</p></div><div class="Section" data-sectioncode="42229-5"><a name="section-9.2"></a><p></p><p class="First"><span class="Italics Underline">Subcutaneous ENTYVIO</span></p><p>ENTYVIO (vedolizumab) injection is supplied as a sterile, clear to moderately opalescent, colorless to slightly yellow, preservative-free solution for subcutaneous administration.</p><p>Each single-dose prefilled syringe or single-dose prefilled pen (ENTYVIO PEN) contains 108 mg vedolizumab, arginine hydrochloride (17.77 mg), citric acid monohydrate (0.18 mg), histidine (3.86 mg), histidine monohydrochloride (1.86 mg), polysorbate 80 (1.35 mg), sodium citrate dihydrate (4.71 mg) and Sterile Water for Injection, USP, at a pH of 6.5.</p></div></section>

Entyvio

vedolizumab

vedolizumab 300 MG Injection

vedolizumab 300 MG Injection [Entyvio]

0.68 ML vedolizumab 159 MG/ML Prefilled Syringe

0.68 ML vedolizumab 159 MG/ML Prefilled Syringe [Entyvio]

0.68 ML vedolizumab 159 MG/ML Auto-Injector

0.68 ML vedolizumab 159 MG/ML Auto-Injector [Entyvio]

University of Kentucky Specialty Pharmacy

Actemra

Afinitor

Alecensa

Alunbrig

Benlysta

Bosulif

Cabometyx

Cosentyx

Enbrel

Erivedge

Erleada

Esbriet

Farydak

Gilotrif

Hemlibra

Ibrance

Imbruvica

Ingrezza

Inlyta

Jakafi

Lonsurf

Lynparza

Mekinist

Mektovi

Nexavar

Ocrevus

Ofev

Promacta

Rituxan

Rubraca

Somatuline Depot

Stelara

Stivarga

Sutent

Tafinlar

Tagrisso

Tarceva

Tasigna

Tecfidera

Temodar

Tykerb

Venclexta

Votrient

Xalkori

Xtandi

Zejula

Zelboraf

Zydelig

Zykadia

Entyvio | University of Kentucky Specialty Pharmacy

Which health plans does University of Kentucky Specialty Pharmacy have contracts with?

Does University of Kentucky Specialty Pharmacy work closely with Entyvio and Takeda Pharmaceuticals America, Inc.?

Does University of Kentucky Specialty Pharmacy offer services for Entyvio patients?

What conditions does University of Kentucky Specialty Pharmacy support?

How does University of Kentucky Specialty Pharmacy help with insurance?